Recombinant Human Active PKA C beta Protein, CF

Catalog # Availability Size / Price Qty
4596-KS-010
Recombinant Human Active PKA C beta Protein SDS-PAGE
1 Image
Product Details
Citations (2)
FAQs
Reviews

Recombinant Human Active PKA C beta Protein, CF Summary

Product Specifications

Purity
>80%, by SDS-PAGE under reducing conditions and visualized by Colloidal Coomassie® Blue stain at 5 μg per lane.
Activity
The specific activity of PKA C beta is typically 423-573 nmol/min/mg using a CREBtide synthetic peptide substrate.
Source
Spodoptera frugiperda, Sf 9 (baculovirus)-derived human PKA C beta protein
Accession #
N-terminal Sequence
Analysis
Using an N-terminal GST tag
SDS-PAGE
65 kDa

Product Datasheets

You must select a language.

x

4596-KS

Carrier Free

What does CF mean?

CF stands for Carrier Free (CF). We typically add Bovine Serum Albumin (BSA) as a carrier protein to our recombinant proteins. Adding a carrier protein enhances protein stability, increases shelf-life, and allows the recombinant protein to be stored at a more dilute concentration. The carrier free version does not contain BSA.

What formulation is right for me?

In general, we advise purchasing the recombinant protein with BSA for use in cell or tissue culture, or as an ELISA standard. In contrast, the carrier free protein is recommended for applications, in which the presence of BSA could interfere.

4596-KS

Formulation Supplied in 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 0.25 mM DTT, 0.1 mM EDTA, 10 mM Glutathione, 0.1 mM PMSF, and 25% Glycerol.
Shipping The product is shipped with dry ice or equivalent. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage: This product is stable at ≤ ‑70 °C for up to 1 year from the date of receipt. For optimal storage, aliquot into smaller quantities after centrifugation and store at recommended temperature. Avoid repeated freeze-thaw cycles.

Assay Procedure

Materials
  • Active Kinase - Active PKA C beta (0.1 μg/μL) diluted with Kinase Dilution Buffer III. Note: These are suggested working dilutions. Optimal dilutions should be determined by each laboratory for each application.
  • Kinase Assay Buffer I - 25 mM MOPS, pH 7.2, 12.5 mM beta -glycerolphosphate, 25 mM MgCl2, 5 mM EGTA, 2 mM EDTA. Add 0.25 mM DTT to the Kinase Assay Buffer I prior to use.
  • Kinase Dilution Buffer III - Kinase Assay Buffer I diluted 5-fold with a 50 ng/μL BSA solution.
  • 10 mM ATP Stock Solution - Prepare the ATP Stock Solution by dissolving 55 mg of ATP in 10 mL of Kinase Assay Buffer. Store 200 μL aliquots at ≤ -20 °C.
  • [33P]-ATP Assay Cocktail - Prepare 250 μM [33P]-ATP Assay Cocktail in a designated radioactive work area by combining 150 μL of 10 mM ATP Stock Solution, 100 μL of [33P]-ATP (1 mCi/100 μL), and 5.75 mL of Kinase Assay Buffer I. Store 1 mL aliquots at ≤ -20 °C.
  • Substrate - CREBtide synthetic peptide substrate (KRREILSRRPSYR) diluted in distilled or deionized water to a final concentration of 1.0 mg/mL.
  1. Thaw the [33P]-ATP Assay Cocktail in a shielded container in a designated radioactive work area.
  2. Thaw the Active PKA C beta, Kinase Assay Buffer I, Substrate, and Kinase Dilution Buffer III on ice.
  3. In a pre-cooled microfuge tube, add the following reaction components bringing the initial reaction volume up to 20 μL:
    a. Diluted Active PKA C beta : 10 μL
    b. Stock solution of Substrate (1.0 mg/mL): 5.0 μL
    c. Distilled or deionized water (4 °C): 5.0 μL
  4. Set up the blank control as outlined in Step 3, excluding the addition of the substrate. Replace the substrate with an equal volume of distilled or deionized water.
  5. Initiate the reaction with the addition of 5 μL [33P]-ATP Assay Cocktail, bringing the final volume up to 25 μL. Incubate the mixture in a water bath at 30 °C for 15 minutes.
  6. After the 15 minute incubation, terminate the reaction by spotting 20 μL of the reaction mixture onto individual pre-cut strips of phosphocellulose P81 paper.
  7. Air dry the pre-cut P81 strip and sequentially wash in a 1% phosphoric acid solution (add 10 mL of phosphoric acid to 990 mL of distilled or deionized water) with constant gentle stirring. It is recommended that the strips be washed a total of three times for approximately 10 minutes each.
  8. Count the radioactivity on the P81 paper in the presence of scintillation fluid in a scintillation counter.
  9. Determine the corrected cpm by subtracting the blank control value (see Step 4) for each sample and calculate the kinase specific activity as outlined below.


    Calculation of [33P]-ATP Specific Activity (SA) (cpm/pmol)
    Specific Activity (SA) = cpm for 5 μL [33P]-ATP/pmol of ATP (in 5 μL of a 250 μM ATP stock solution; i.e. 1250 pmol)

    Calculation of Kinase Specific Activity (SA) (pmol/minutes/μg or nmol/minutes/mg)
    Corrected cpm from reaction / [(SA of [33P]-ATP in cpm/pmol) x (Reaction time in minutes) x (Enzyme amount in μg or mg)] x [(Reaction volume) / (Spot Volume)]

Scientific Data

SDS-PAGE Recombinant Human Active PKA C beta Protein SDS-PAGE View Larger

The approximate molecular weight is 65 kDa and the purity is > 80%.

Reconstitution Calculator

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Background: PKA C beta

The catalytic subunit C-beta of PKA (PKA C beta ) is a member of the Ser/Thr protein kinase family (the PKA catalytic subunit consists of three gene products: C alpha, C beta, and C gamma ) and has been assigned to human chromosome region 1p36.1 (1). PKA C beta is derived from a gene distinct from C alpha and shows tissue-specific expression. At the amino acid level C alpha and C beta showed 93% homology.

References
  1. Simard, J. et al. (1992) Human Genetics 88:653.
Long Name
cAMP-dependent Protein Kinase Catalytic Subunit beta
Entrez Gene IDs
5567 (Human); 18749 (Mouse); 293508 (Rat)
Alternate Names
cAMP-dependent protein kinase catalytic beta subunit isoform 4ab; cAMP-dependent protein kinase catalytic subunit beta; cAPKbeta; DKFZp781I2452; EC 2.7.11; EC 2.7.11.11; MGC41879; MGC9320; PKA C beta; PKA C-beta; PKACb; PRKACB; protein kinase A catalytic subunit beta; protein kinase, cAMP-dependent, catalytic, beta

Citations for Recombinant Human Active PKA C beta Protein, CF

R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.

2 Citations: Showing 1 - 2
Filter your results:

Filter by:

  1. Chromosomal instability during neurogenesis in Huntington's disease
    Authors: A Ruzo, GF Croft, JJ Metzger, S Galgoczi, LJ Gerber, C Pellegrini, H Wang, M Fenner, S Tse, A Marks, C Nchako, AH Brivanlou
    Development, 2018-01-29;145(2):.
    Species: Human
    Sample Types: Whole Cells
    Applications: Differentiation, Differentiation
  2. Cross-talk between PKA-Cbeta and p65 mediates synergistic induction of PDE4B by roflumilast and NTHi.
    Authors: Susuki-Miyata S, Miyata M, Lee B, Xu H, Kai H, Yan C, Li J
    Proc Natl Acad Sci U S A, 2015-03-23;112(14):E1800-9.
    Species: Human
    Sample Types: Recombinant Protein
    Applications: Enzyme Assay

FAQs

No product specific FAQs exist for this product, however you may

View all Proteins and Enzyme FAQs

Reviews for Recombinant Human Active PKA C beta Protein, CF

There are currently no reviews for this product. Be the first to review Recombinant Human Active PKA C beta Protein, CF and earn rewards!

Have you used Recombinant Human Active PKA C beta Protein, CF?

Submit a review and receive an Amazon gift card.

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review